Liquidity Events
Venture Catalysts exits health supplements seller TruNativ with 12.7x return
Venture Catalysts has completed a full exit from the nutrition and wellness firm TruNativ , following two funding rounds. The initial investment made in June 2021 generated a 12.73x return multiple and an approximate 67% internal rate of return (IRR) over a five-year holding period. The follow-on investment executed in September 2024, through the angel fund, yielded a 1.34x multiple and an 18% IRR over a 21-month period. (The company recently attracted funding from OrbiMed, Rainmatter and Emami.)Founded in 2019, TruNativ is a direct-to-consumer brand with a product portfolio which includes a heat-resistant, flavourless whey protein designed for Indian cooking, alongside natural sugar replacers, collagen, and prebiotic fibres, all aimed at addressing macronutrient deficiencies.
Between Mar 2022 and Jun 2026, TruNativ had attracted about $34-M from Rainmatter Capital, Stride Ventures, Z Nation Lab, Trifecta Capital, OrbiMed and others.For FY25, TruNativ had reported about Rs.38-Cr in Operating Income and about Rs.13-Cr in Net Loss.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
